Graphite Bio, Inc. [Rocket]

Overview

Graphite Bio, Inc.

Add to portfolio

Recent News + Filings (All items)

Date Filed	Type	Description
08/23/2023	8-K	Cost Associated with Exit or Disposal Activities, Departure of Directors or Certain Officers; Election of Directors; Appointm...
08/14/2023	10-Q	Quarterly Report for the period ended June 30, 2023
08/02/2023	8-K	Appointed a new director
08/01/2023	4	Form 4 - Statement of changes in beneficial ownership of securities:
08/01/2023	3	Form 3 - Initial statement of beneficial ownership of securities:
07/21/2023	4	Form 4 - Statement of changes in beneficial ownership of securities:
07/21/2023	4	Form 4 - Statement of changes in beneficial ownership of securities:

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-22	Dec-05-22	Dec-31-21	Dec-05-21	Dec-31-20	Dec-31-19
Revenues	0.0	72.8	0.0	37.9	0.0	0.0
Revenue growth		91.9%
Cost of goods sold	0.0	105.6	0.0	60.4	0.0	0.0
Gross profit	0.0	-32.9	0.0	-22.5	0.0	0.0
Gross margin		-45.1%		-59.3%
Selling, general and administrative	105.6		60.4
Research and development					9.1
General and administrative		32.9		22.5	4.4	0.0
EBIT	-96.5	-105.6	-81.1	-60.4	-13.5	0.0
EBIT margin		-145.1%		-159.3%
Pre-tax income	-101.1	-101.1	-70.8	-70.8	-68.4	0.0
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-101.1	-101.1	-70.8	-70.8	-68.4	0.0
Net margin		-138.8%		-186.5%

Diluted EPS	($1.84)	($1.84)	($2.45)	($2.45)	($29.93)
Shares outstanding (diluted)	54.9	54.9	28.9	28.9	2.3

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.